Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J McCluskie

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Drug Targets. Infectious Disorders|November 29, 2002
Novel adjuvant systemsM J McCluskie, R D Weeratna
Critical Reviews in Immunology|October 26, 1999
Novel strategies using DNA for the induction of mucosal immunityM J McCluskie, H L Davis
Vaccine|October 12, 2000
Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvantsM J McCluskie, H L Davis
Current Topics in Microbiology and Immunology|October 20, 2006
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNAM J McCluskie, A M Krieg
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to miceM J McCluskie, H L Davis
Microbes and Infection|December 14, 1999
DNA vaccines for viral diseasesH L Davis, M J McCluskie
Microbes and Infection|December 28, 1999
Mucosal immunization with DNA vaccinesM J McCluskie, H L Davis
Methods in Molecular Medicine|March 5, 2011
Mucosal immunization with DNA vaccinesM J McCluskie, H L Davis
Vaccine|March 21, 2001
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvantsM J McCluskie, R D Weeratna, H L Davis
Springer Seminars in Immunopathology|August 17, 2000
The role of CpG in DNA vaccinesM J McCluskie, R D Weeratna, H L Davis
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Drug Targets. Infectious Disorders|November 29, 2002
Novel adjuvant systemsM J McCluskie, R D Weeratna
Critical Reviews in Immunology|October 26, 1999
Novel strategies using DNA for the induction of mucosal immunityM J McCluskie, H L Davis
Vaccine|October 12, 2000
Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvantsM J McCluskie, H L Davis
Current Topics in Microbiology and Immunology|October 20, 2006
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNAM J McCluskie, A M Krieg
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to miceM J McCluskie, H L Davis
Microbes and Infection|December 14, 1999
DNA vaccines for viral diseasesH L Davis, M J McCluskie
Microbes and Infection|December 28, 1999
Mucosal immunization with DNA vaccinesM J McCluskie, H L Davis
Methods in Molecular Medicine|March 5, 2011
Mucosal immunization with DNA vaccinesM J McCluskie, H L Davis
Vaccine|March 21, 2001
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvantsM J McCluskie, R D Weeratna, H L Davis
Springer Seminars in Immunopathology|August 17, 2000
The role of CpG in DNA vaccinesM J McCluskie, R D Weeratna, H L Davis
Pageof 3